Dimethylamine

Dimethylamine

SCHEMBL4538

CNC.Cc1ccccc1B(O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.43
TSHR P16473 2/20 0.43
ACHE P22303 2/20 0.43
MAPT P10636 1/20 0.39
ORAI1 Q96D31 1/20 0.37
ORAI2 Q96SN7 1/20 0.37
ORAI3 Q9BRQ5 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
LIPG Q9Y5X9 1/20 0.36
ALDH1A1 P00352 4/20 0.36
CA7 P43166 2/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
HPGD P15428 1/20 0.35
LIPE Q05469 1/20 0.35
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9131 0.92 TSHR (0.50) ENPP2TSHRACHEMAPTORAI1
SCHEMBL28083714 0.92 TSHR (0.50) ENPP2TSHRACHEMAPTORAI1
SCHEMBL29392408 0.92 TSHR (0.50) ENPP2TSHRACHEMAPTORAI1
Ammonia Solution, Strong SCHEMBL27982010 0.90 TSHR (0.47) ENPP2TSHRACHEMAPTORAI1
Water SCHEMBL28105165 0.90 TSHR (0.47) ENPP2TSHRACHEMAPTORAI1
Diethylamine SCHEMBL1133302 0.82 LIPG (0.40) ENPP2TSHRACHEMAPTORAI1
SCHEMBL2323835 0.82 ENPP2 (0.38) ENPP2TSHRACHEORAI1ORAI2
SCHEMBL7032190 0.79 ORAI1 (0.50) ENPP2TSHRACHEORAI1ORAI2
Tolyl Boronic Acid SCHEMBL28299771 0.78 CA2 (0.67) ENPP2TSHRORAI1ORAI2ORAI3
SCHEMBL12270850 0.77 TSHR (0.45) ENPP2TSHRACHEORAI1ORAI2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946476-B2 Process for the preparation of amino acid derivatives UCB PHARMA GMBH (DE) 2015-02-03 US claimed
US-8501993-B2 Processes for the preparation of amides SYNGENTA LIMITED (GB) 2013-08-06 US claimed
EP-2352721-B1 NOVEL PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES UCB PHARMA GMBH (DE) 2013-03-27 EP claimed
US-20120289707-A1 PROCESS FOR THE PREPARATION OF AMIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-11-15 US claimed
US-8227619-B2 Process for the preparation of amides SYNGENTA LIMITED (GB) 2012-07-24 US claimed
US-20110263899-A1 Novel Process for the Preparation of Amino Acid Derivatives UCB PHARMA GMBH (DE) 2011-10-27 US claimed
US-20110178310-A1 PROCESS FOR THE PREPARATION OF AMIDES SYNGENTA CROP PROTECTION, INC. (US) 2011-07-21 US claimed
US-20110071315-A1 PROCESSES FOR THE PREPARATION OF AMIDES SYNGENTA CROP PROTECTION, INC. (US) 2011-03-24 US claimed
US-11820769-B2 Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same YUHAN CORPORATION (KR) 2023-11-21 US disclosed
US-20220024918-A1 TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME YUHAN CORPORATION (KR) 2022-01-27 US disclosed
EP-3894408-A1 TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Yuhan Corporation (KR) 2021-10-20 EP disclosed
US-11091479-B2 Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same YUHAN CORPORATION (KR) 2021-08-17 US disclosed
US-11045796-B2 Process for producing aromatic compound, and palladium complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 US disclosed
US-20200223844-A1 TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME YUHAN CORPORATION (KR) 2020-07-16 US disclosed
US-20040161404-A1 Method for producing coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-19 US disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed
EP-1439157-A2 Method for producing Suzuki coupling compound catalysed by a nickel compound Sumitomo Chemical Co.,Ltd. (JP) 2004-07-21 EP disclosed
EP-1437354-A1 4-OXOQUINOLIZINE ANTIMICROBIALS HAVING 2-PYRIDONE SKELETON AS PARTIAL STRUCTURE Sato Pharmaceutical Co. Ltd. (JP) 2004-07-14 EP disclosed
US-20040024229-A1 Production method for biarylalanine SUMITOMO CHEMICAL COMPANY, LIMITED 2004-02-05 US disclosed
EP-1346971-A1 Production method for biarylalanine SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11091479-B2 Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same VAPB, HDLBP, VAPA ENPP2 4258/4885TSHR 929/4885ACHE 4153/4885
US-20110071315-A1 PROCESSES FOR THE PREPARATION OF AMIDES PAH, CYP3A4, AKR7A2 ENPP2 1178/4885TSHR 2384/4885ACHE 357/4885
US-11820769-B2 Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same VAPB, HDLBP, VAPA ENPP2 4258/4885TSHR 929/4885ACHE 4153/4885
US-11045796-B2 Process for producing aromatic compound, and palladium complex DDT, DRD1, DRD2 ENPP2 3424/4885TSHR 1067/4885ACHE 2494/4885
US-20040024229-A1 Production method for biarylalanine BCAT2, BCAT1, PAH ENPP2 4186/4885TSHR 1972/4885ACHE 3484/4885
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 ENPP2 3832/4885TSHR 1200/4885ACHE 3905/4885
US-20200223844-A1 TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME VAPB, HDLBP, VAPA ENPP2 4258/4885TSHR 929/4885ACHE 4153/4885
US-20110178310-A1 PROCESS FOR THE PREPARATION OF AMIDES H1-5, CYP3A5, CYP2B6 ENPP2 958/4885TSHR 384/4885ACHE 231/4885
US-20110263899-A1 Novel Process for the Preparation of Amino Acid Derivatives BCAT2, DNPEP, NPEPPS ENPP2 842/4885TSHR 3569/4885ACHE 1598/4885
US-20220024918-A1 TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME VAPB, HDLBP, VAPA ENPP2 4258/4885TSHR 929/4885ACHE 4153/4885
US-20120289707-A1 PROCESS FOR THE PREPARATION OF AMIDES CHRM2, CHRM1, CYP1B1 ENPP2 856/4885TSHR 288/4885ACHE 204/4885
US-20040161404-A1 Method for producing coupling compound PYM1, MALT1, BET1 ENPP2 807/4885TSHR 423/4885ACHE 4735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.